Author avatar

Dr. Umar Aitsaam

About

Clinical Pharmacist and Master’s student in Clinical Pharmacy with research interests in pharmacovigilance, behavioral interventions in mental health, and AI applications in clinical decision support. Experience includes digital health research with Bloomsbury Health (London) and pharmacovigilance practice in patient support programs. Published work covers drug awareness among healthcare providers, postpartum depression management, and patient safety reporting.

Recent Posts

2025-10-30 13:45:57

FDA’s Closer to Zero Initiative: Translating Toxicology into Infant Food Policy

The FDA’s Closer to Zero initiative aims to reduce toxic heavy metals—lead, arsenic, cadmium, and mercury—in baby foods to the lowest feasible levels. By setting evidence-based action levels, it bridges toxicology and policy to protect infants’ neurodevelopment while ensuring nutritional adequacy and industry feasibility.

2025-10-30 12:40:04

Heavy Metal Content in Polish Baby Foods: Safety & Risk Review

Most Polish ready-to-eat baby foods are within EU heavy metal limits, but isolated exceedances—mainly of lead and mercury—highlight the need for ongoing monitoring and targeted controls in high-risk product categories for effective certification.

2025-10-30 10:57:22

Heavy Metal Limits in Baby Food: Findings for HMTC

The staff report quantifies widespread arsenic, lead, cadmium, and mercury in U.S. baby foods and shows why heavy metal limits in baby food must be unified, lower, and enforced via finished-product testing.

2025-10-30 08:29:39

FDA Infant Rice Cereal Inorganic Arsenic: HMTC Insights

FDA infant rice cereal inorganic arsenic testing in 2018 found 76% of products met 100 ppb, up from 36% in 2011–2013, demonstrating feasible compliance and highlighting sourcing and GMP controls for HTMC alignment.